NCT05330962

Brief Summary

The study aim to assess cardiovascular risk score among patients of AlHadary primary health care centre in Waldeya, Assiut governorate. And to determine the awareness about cardiovascular risk among these patients as well.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
383

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 15, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

August 10, 2022

Status Verified

August 1, 2022

Enrollment Period

6 months

First QC Date

April 10, 2022

Last Update Submit

August 9, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Framingham study cardiovascular disease 10 years risk assessment results

    Participants will be categorized into four risk groups based on the 10 years ASCVD risk percentages.

    1 year

Secondary Outcomes (1)

  • Total cardiovascular disease knowledge score results

    1 year

Interventions

A personal interview questionnaire

Also known as: ASCVD risk estimator

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Attendees of primary health care centre, Assiut governorate.

You may qualify if:

  • Male 30-65 years old, or female 40-70 years old.

You may not qualify if:

  • History of ischemic heart disease, stroke, transitory ischemic attack (TIA) or peripheral artery disease (PAD) in electronic health record.
  • History of diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Yacoub M, Mayosi B, ElGuindy A, Carpentier A, Yusuf S. Eliminating acute rheumatic fever and rheumatic heart disease. Lancet. 2017 Jul 15;390(10091):212-213. doi: 10.1016/S0140-6736(17)31608-2. No abstract available.

Related Links

Central Study Contacts

Dalia G Mahran, Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
registrar

Study Record Dates

First Submitted

April 10, 2022

First Posted

April 15, 2022

Study Start

November 1, 2022

Primary Completion

May 1, 2023

Study Completion

June 1, 2023

Last Updated

August 10, 2022

Record last verified: 2022-08